MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.710
+0.320
+13.39%
After Hours: 2.700 -0.01 -0.37% 19:27 11/15 EST
OPEN
3.010
PREV CLOSE
2.390
HIGH
3.380
LOW
2.550
VOLUME
9.51M
TURNOVER
--
52 WEEK HIGH
24.45
52 WEEK LOW
2.160
MARKET CAP
9.33M
P/E (TTM)
-0.0012
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PSTV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PSTV News

  • Mid-Day Market Update: Dow Up 150 Points; Limbach Holdings Shares Slide
  • Benzinga.7h ago
  • Mid-Morning Market Update: Markets Open Higher; JC Penney Reports Narrower-Than-Expected Q3 Loss
  • Benzinga.9h ago
  • The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
  • Benzinga.12h ago
  • Plus Therapeutics EPS beats by $5.82
  • seekingalpha.22h ago

More

Industry

Biotechnology & Medical Research
+1.49%
Pharmaceuticals & Medical Research
+1.29%

Hot Stocks

Name
Price
%Change

About PSTV

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
More

Webull offers Plus Therapeutics Inc (PSTV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.